indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

Pluss Advanced Technologies receives Rs 50 lakh grant under the Millennium Alliance Programme by FICCI

IMT News Desk
Gurugram based Pluss Advanced Technologies Pvt Ltd., which deals in research and indigenous development of PCMs, has received Rs 50 lakh grant under the Millennium Alliance Programme by FICCI. The grant will be utilised in building capacity among Indian hospitals and neonatal care units to tackle Neonatal deaths in India using MiraCradle™- an Indian Invention to treat newborn babies born with birth asphyxia. MiraCradle™, a neonate cooler (a patent pending), is a CE certified device which is available in over 130 private hospitals in India. Till date, over 5000 new born babies have been treated using this device – giving them the right to live. The award was presented by Hon’ble Dr. Harsh Vardhan, Union Minister for Science & Technology, Earth Sciences, Environment, Forests and Climate Change, Govt. of India. "India accounts for more than a quarter (26 per cent) of the world’s neo-natal deaths. The states of Uttar Pradesh, Madhya Pradesh, Rajasthan and Bihar contribute to more than half of newborn deaths in India. We have chosen Rajasthan as the state to create capacity to tackle birth asphyxia”, said Samit Jain, Managing Director, Pluss Advanced Technologies Pvt. Ltd. “Birth Asphyxia treatment has always been a challenge in India due to imported devices which costs over Rs. 15 Lakhs. MiraCradle™ is the world’s first such affordable device for treatment of birth asphyxia in neonates. We have successfully worked with partners in South Africa and the device is today a standard method of care for birth asphyxia with 4 major government hospitals in South Africa using it. We hope to make this a reality in India too.”, he further added. MiraCradle™ was designed and developed in partnership with Christian Medical College, Vellore which undertook all clinical trials required for product approvals. “We aim to address the Sustainable Development Goals set by United Nations with regard to Neonatal Mortality.  We are targeting low and middle income countries and the device has been recognized by the WHO in its Compendium of Innovative and Affordable Health Care technologies. Besides South Africa, we are now working in Kenya, Vietnam, Thailand, Turkey and will soon spread to other countries. ”said Ankit Jhanwar, Vice President Corporate Planning, Pluss. A pioneer in advanced Phase Change Materials Technology (PCM), Pluss is the only Indian company engaged in research and indigenous development of PCMs for a wide range temperature requirement with several patents. Solutions from PLUSS help address the growing energy requirements for temperature control. Pluss is focused on creating value for its customers by designing innovative products and solutions in the field of Speciality Polymers and Phase Change Materials. Pluss is a venture funded organization with equity stake being held by Tata Capital Innovation fund, a premium fund of the TATA group from India. With its innovative products, Pluss Advanced Technologies is making its presence felt across the globe with representatives in USA, Turkey, South East Asia, Russia, Ukraine and South Africa. Pluss intends to be amongst the top innovative companies in the world in the near future.

Recommended

India Rejects UK’s Data Exclusivity Demand to Protect Generic Drug Sector

Morepen Board proposes dividend after 23 years

Kenvue, IAP Delhi highlight effectiveness of colloidal oatmeal in skincare

BorderPlus commits Rs 10 crore in scholarships for Indian nurses

Aakash Healthcare organises CME event on paediatric nephrology

India Nears SDG 2030 Targets with Significant Drop in Maternal and Child Mortality

Dr Reddy’s posts consolidated revenue of Rs 85.1 bn in Q4 Fy25

Dr. Reddy’s Sets Sights on Top Five: A Bold Push in the Indian Market

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions